Ischemic stroke in elderly patients treated with a free radical scavenger-glycolytic intermediate solution: A preliminary pilot trial

Neurological Research

Volumn 24, Issue 1, 2002, Pages 73-80

  Karaca M ^a   Kilic E ^a   Yazici, B ^a   Demir, S ^a   De La Torre, J ^b  

^a Ihlas Medical Center   (Turkey)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebral blood flow; Clinical trial; Dimethyl sulfoxide; Fructose 1,6 diphosphate; Ischemic stroke; Neuroprotection

Indexed keywords

DIMETHYL SULFOXIDE; DIMETHYL SULFOXIDE FRUCTOSE 1,6 DIPHOSPHATE; FRUCTOSE 1,6 BISPHOSPHATE; PHA 56; SCAVENGER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONSCIOUSNESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NEUROLOGIC DISEASE; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; SCORING SYSTEM; SIDE EFFECT;

ADULT; AGED; AGING; BRAIN; BRAIN EDEMA; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; DIMETHYL SULFOXIDE; DRUG COMBINATIONS; FEMALE; FREE RADICAL SCAVENGERS; FRUCTOSEDIPHOSPHATES; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; SODIUM CHANNELS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036138320     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164102101199567     Document Type: Article

References (52)

1. Ischemic stroke: Relation of age, lesion location, and initial neurologic deficit to functional outcome
2. Epidemiology of adverse drug reactions in the elderly by drug class
3. Dimethyl sulfoxide prevents DNA nicking mediated by ionizing radiation or iron-hydrogen peroxide-generated hydroxyl radical
4. The hydroxyl radical scavengers dimethyl sulfoxide and dimethyl urea protect rats against thioacetamide-induced fulminant hepatic failure
5. Dimethyl sulfoxide increases latency of anoxic terminal negativity in hippocampal slices of guinea pig in vitro
6. Antiplatelet effect of dimethyl sulfoxide, barbiturates, and methyl prednisolone
7. The effect of dimethyl sulfoxide on the water transport response of rat hepatocytes during freezing
8. Cooling and freezing damage platelet membrane integrity
9. Synergistic activity of combined prostacyclin: Dimethyl sulfoxide in experimental brain ischemia
10. Dimethyl sulfoxide therapy following penetrating brain injury
11. Dimethyl sulfoxide for the management of post-operative hemiplegia
12. Dimethyl sulfoxide for the treatment of intracranial hypertension
13. Dimethyl sulfoxide lowers intracranial pressure after closed head trauma
14. Dimethyl sulfoxide in the management of patients with brain swelling and increased intracranial pressure after severe, closed head injury
15. Protective effects of methyl prednisolone and dimethyl sulfoxide in experimental middle cerebral artery embolectomy
16. Treatment of post-ischemic brain with a free radical scavenger and a platelet activating factor antagonist: Recovery of metabolism and function
17. Protective effects of the free radical scavengers, dimethyl sulfoxide and ethanol, in cerebral ischemia in gerbils
18. Dimethyl sulfoxide treatment reduces infarction volume after permanent focal cerebral ischemia in rats
19. Dexamethasone and dimethyl sulfoxide in experimental transorbital cerebral infarction
20. Hemodynamics and metabolic effects of fructose 1,6-diphosphate in ischemia and shock: Experimental and clinical observations
21. 2+transport ATPase
22. Fructose 1,6-diphosphate preserves ATP but not intracellular pH during hypoxia in respiring neonatal rat brain slices
23. Fructose 1,6-biphosphate after hypoxic ischemic injury is protective to the neonatal brain
24. Reversal of ischemic-induced chronic memory dysfunction in aging rats with a free radical scavenger-glycolytic intermediate combination
25. Treatment of head injury in mice using a fructose 1,6-diphosphate-dimethyl sulfoxide combination
26. Treatment of acute cerebral infarction with a choline precursor in a multi-center, double blind placebo-controlled study
27. The acute stroke patient: The first 6 hours
28. Tissue plasminogen activator for acute ischemic stroke
29. Neuroprotection for acute stroke: Making clinical trials work
30. Cost-effectiveness analysis of anti-platelet therapy in the prevention of recurrent stroke in the UK. Aspirin, dipyridamole and aspirin-dipyridamole
31. Clinical trials with neuroprotective drugs in acute ischemic stroke: Are we doing the right thing?
32. Oxygen radicals in cerebral vascular injury
33. Pathophysiology of the ischemic penumbra-revision of a concept
34. Anti-adhesion molecule and nitric oxide protection strategies in ischemic stroke
35. The role of inflammation after acute stroke: Utility of pursuing anti-adhesion molecule therapy
36. Factors determining the therapeutic window in acute ischemic stroke: Characteristics of PET studies
37. Neurological deterioration in acute ischemic stroke: Potential predictors and associated factors in the European cooperative acute stroke study (ECASS)
38. Lubeluzole protects hippocampal neurons from excitotoxicity in vitro and reduces brain damage caused by ischemia
39. Antagonizing excitotoxicity: A therapeutic strategy for stroke?
40. Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease
41. + channels as targets for neuroprotective drugs
42. Treatment of inflammation processes of the lower urinary tract with dimethyl sulfoxide
43. Topically applied dimethyl sulfoxide. Its effects on inflammation and healing of contusion
44. Acute dimethyl sulfoxide therapy in brain edema. Part 3: Effect of a 3-hour infusion
45. Dimethyl sulfoxide in CNS trauma
46. An experimental study on the effects of DMSO and indomethacin on cerebral circulation and intracranial pressure
47. Efficacy and tolerability of lifarizine in acute ischemic stroke. A pilot study
48. Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons
49. The importance of voltage-dependent sodium channels in cerebral ischaemia
50. Prevention of ischemic-hypoxic brain injury and death in rabbits with fructose 1,6-diphosphate
51. Fructose 1,6-diphosphate: An agent for treatment of experimental endotoxin shock
52. Dimethyl sulfoxide suppresses NMDA- and AMPA-induced ion currents and calcium influx and protects against excitotoxic death in hippocampal neurons